GSA Capital Partners’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-37,404
| Closed | -$772K | – | 1584 |
|
|
2023
Q3 | $772K | Buy |
+37,404
| New | +$772K | 0.07% | 537 |
|
|
2022
Q2 | – | Sell |
-6,940
| Closed | -$223K | – | 1480 |
|
|
2022
Q1 | $223K | Buy |
6,940
+1,106
| +19% | +$35.5K | 0.03% | 1109 |
|
|
2021
Q4 | $260K | Sell |
5,834
-9,058
| -61% | -$404K | 0.03% | 1036 |
|
|
2021
Q3 | $751K | Buy |
+14,892
| New | +$751K | 0.08% | 454 |
|
|
2021
Q2 | – | Sell |
-5,583
| Closed | -$319K | – | 1368 |
|
|
2021
Q1 | $319K | Buy |
+5,583
| New | +$319K | 0.05% | 604 |
|
|
2019
Q3 | – | Sell |
-25,564
| Closed | -$531K | – | 1461 |
|
|
2019
Q2 | $531K | Buy |
25,564
+16,244
| +174% | +$337K | 0.06% | 633 |
|
|
2019
Q1 | $216K | Buy |
+9,320
| New | +$216K | 0.02% | 1202 |
|